Table 3.
Section A: Are the Results of the Trial Valid? | Section B: What are the Results? | Section C: Will the Results Help Locally? | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Authors, Year | Item 1 | Item 2 | Item 3 | Item 4 | Item 5 | Item 6 | Item 7 | Item 8 | Item 9 | Item 10 | Item 11 | Total Quality Score (0–11) |
Uemura et al. (2019) | Yes | Yes | Yes | No | Yes | Yes | Treatment improved statistically | Yes | No | Yes | Yes | 9 |
Stevens et al. (2019) | Yes | Yes | Yes | Yes | Yes | Yes | Treatment improved statistically | Yes | No | Yes | Yes | 10 |
Khine et al. (2020) | Yes | Yes | Yes | No | No | Yes | Treatment improved statistically | Yes | No | Yes | Yes | 8 |
CASP, Critical Appraisal Skills Program. Item 1: Was the study issue is clearly focused?; Item 2: Was the assignment of patients to treatments randomized?; Item 3: Were all of the patients who entered the trial properly accounted for at its conclusion?; Item 4: Were patients, health workers and study personnel “blind” to treatment?; Item 5: Were the groups similar at the start of trial; Item 6: Aside from the experimental intervention, were the groups treated equally?; Item7: How large was the treatment effect?; Item 8:How precise was the estimate of the treatment effect?; Item 9: Can the results be applied to the local population, on in your context?; Item 10: Were all clinically important outcomes considered?; Item 11: Are the benefits worth the harms and costs?